Email info@neudata.co
Request a trial

How to Profit from FOIA Requests: Investor Case Studies

Brittany Thomas, Senior Regulatory Analyst (New York)

Neudata Intelligence
Post feature

We previously highlighted a study which found that institutional investors are using Freedom of Information Act (FOIA) requests – specifically, FDA FOIA requests – to generate abnormal returns. In this piece, we provide three examples of how investors have successfully utilised this FOIA technique to obtain early access to stock-moving information.

NEUDATA QUICK VIEW

We believe that information obtained through FOIA requests can serve as a valuable supplementary source of intelligence for equity investors. Supporting this

Request a Neudata trial

We'd like to know a bit more about you and your business, so we can deal with your request efficiently.
We take your privacy seriously and handle your personal data in line with our privacy statement.

We use your email address as part of allowing you access to your account and in order to provide you details with our products that might be of interest to you

Already got an account? Sign in now